Design, synthesis, and antitumor activity evaluation of novel acyl sulfonamide spirodienones

Bioorg Med Chem. 2022 Apr 15:60:116626. doi: 10.1016/j.bmc.2022.116626. Epub 2022 Jan 11.

Abstract

Based on the promising results of benzenesulfonamide spirodienones as antineoplastic agents, we have designed and synthesized a series of novel acyl sulfonamides spirodienone for antineoplastic evaluation. Of these, compound 4a exhibited remarkable in vitro antiproliferative activity by arresting the cell cycle and inducing apoptosis of MDA-MB-231 cells. Acute toxicity study has demonstrated 4a at 100 mg/kg dose caused no obvious toxicity to the major organs of mice. Moreover, compound 4a suppressed the growth of murine 4T1 tumor in vivo. Preliminary enzyme assay showed that 4a was a potential MMP2 inhibitor for cancer therapy. In all, these results indicate that compound 4a may be a lead compound for the development of anticancer agents.

Keywords: Acyl sulfonamides spirodienone; Anti-proliferation; Apoptosis; MMP2 inhibitor.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antineoplastic Agents* / pharmacology
  • Apoptosis
  • Cell Line, Tumor
  • Cell Proliferation
  • Dose-Response Relationship, Drug
  • Drug Screening Assays, Antitumor
  • Mice
  • Molecular Structure
  • Structure-Activity Relationship
  • Sulfonamides* / pharmacology

Substances

  • Antineoplastic Agents
  • Sulfonamides